LLY NYSE

Eli Lilly

Follow Open structure map Ask about this Research this company

Description

LLY · NYSE

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

Wikipedia · CC BY-SA 4.0

Headquarters: US
Reporting currency: USD
Website: Website

Structure of Eli Lilly

Eli Lilly

Company

2 connections

PeersCompetition and partners

OwnershipInvestment and holdings1 of 2

Relationship began2026Unsorted nodes

Eli LillyCompany · 2 connections

Layer 1

PeersCompetition and partners1

OwnershipInvestment and holdings1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

Innoventpartners with →Eli Lilly
Company · InnoventEvidence 1
Fact90%
View evidence
- CompanyPR Newswire news releases2026-10-09
  Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
  View source
Forbioninvests in →Eli Lilly
Company · ForbionEvidence 1
Fact55%
View evidence
- MediaBioPharma Dive2026-10-07 02:04
  View source
Forbionfinances →Eli Lilly
Company · ForbionEvidence 1
Fact55%
View evidence
- MediaBioPharma Dive2026-10-07 02:04
  View source
Eli Lillyinvests in →radiopharmaceuticals
Technology · radiopharmaceuticalsEvidence 1
Fact55%
View evidence
- MediaFierce Healthcare
  View source

Showing 1 to 4 of 4

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

partners withInnovent

Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.

PR Newswire news releases · 2026-10-09

View evidence

CompanyPR Newswire news releases2026-10-09
Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
View source

FactEvidence 1

invests inForbion

No public evidence summary is available.

BioPharma Dive · 2026-10-07 02:04

View evidence

MediaBioPharma Dive2026-10-07 02:04
View source

FactEvidence 1

financesForbion

No public evidence summary is available.

BioPharma Dive · 2026-10-07 02:04

View evidence

MediaBioPharma Dive2026-10-07 02:04
View source

FactEvidence 1

invests inradiopharmaceuticals

No public evidence summary is available.

Fierce Healthcare

View evidence

MediaFierce Healthcare
View source

Showing 1 to 4 of 4

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Filings

Not available: Company signals · Financials · Guidance